In bladder cancer, MAFG-DT was significantly upregulated, and this was associated with advanced clinical and pathological features, which promoted bladder cancer progression by regulating the miR-143-3p/COX-2 signaling axis (19). Here, MILIP is linked to urinary bladder carcinoma.